The healthcare field is witnessing a significant shift in glucose care with the arrival of GLP-1 transdermal devices. These groundbreaking vehicles offer a potentially simple choice to subcutaneous injections for individuals living with diabetes. By avoiding the need for frequent pokes, GLP-1 adh